Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors' Attention Today
U.S. markets continued their weak trend on Wednesday, with next week’s Federal Open Market Committee meeting beginning to weigh on investors’ minds. The Nasdaq and the S&P 500 closed marginally in the red, while the Dow ended the session flat. Here are five stocks that are drawing retail…#crohn #yvonnechan #gamestopcorp #tesla #federalopenmarketcommittee #southeastasias #iphone #teslainc #thailand #pra023 (Source: Reuters: Health)
Source: Reuters: Health - December 8, 2022 Category: Consumer Health News Source Type: news
Why This Small Biotech Stock Just Rocketed 176%
Prometheus Biosciences (RXDX) reported promising results for one of its drugs in two inflammatory disease studies on Wednesday, and RXDX stock catapulted by triple digits.X The company studied its drug, currently dubbed PRA023, in patients with ulcerative colitis and Crohn's disease, two forms of…#buckingrecentnegativepressure #pra023 #pfe #crohn #rxdxstocktargetingaligandprometheu #gregoryrenza #svbsecurities #rbccapitalmarkets #pfizerroivant #rbc (Source: Reuters: Health)
Source: Reuters: Health - December 7, 2022 Category: Consumer Health News Source Type: news
Lifestyle Modification Can Reduce Proportion of IBD Burden
WEDNESDAY, Dec. 7, 2022 -- A considerable proportion of the burden of ulcerative colitis (UC) and Crohn disease (CD) could be prevented by lifestyle modification, according to a study published online Dec. 6 in Gut.
Emily W. Lopes, M.D., M.P.H.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 7, 2022 Category: Pharmaceuticals Source Type: news
Horrified mum told she had Crohn's disease and given just 14 months to live
It was only when 39-year-old Alex Jamieson began suffering severe pain that surgeons discovered the truth. (Source: Daily Express - Health)
Source: Daily Express - Health - December 3, 2022 Category: Consumer Health News Source Type: news
Consumer Health: Who is at risk for inflammatory bowel disease?
Crohn ’s and Colitis Awareness Week will be observed Dec. 1 –7, which makes this a good time to learn about the risk factors for developing these disorders. Researchers estimate that more than half a million people in the U.S. have Crohn ’s disease, and 600,000 to 900,000 people in the U.S. have ulcerative colitis, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Inflammatory bowel disease is an umbrella term used to describe disorders that involve chronic inflammation of your… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 1, 2022 Category: Databases & Libraries Source Type: news
Crohn ’s Disease Doesn’t Define Me
Christina Difeo Petrella’s life with Crohn’s. (Source: WebMD Health)
Source: WebMD Health - November 17, 2022 Category: Consumer Health News Source Type: news
A Cure for Crohn ’s: How Close Are We?
A Crohn’s disease researcher talks about the quest for a cure and better treatments. (Source: WebMD Health)
Source: WebMD Health - November 17, 2022 Category: Consumer Health News Source Type: news
How to Stay Connected When You Have Crohn ’s
Tips for keeping an active social life when you're managing Crohn's disease symptoms in your daily life. (Source: WebMD Health)
Source: WebMD Health - November 14, 2022 Category: Consumer Health News Source Type: news
Crohn's disease: 'I lived on bran flakes and sweets for a year'
Sianny Thomas says gummy sweets were the only only thing she could eat without being in pain. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 2, 2022 Category: Consumer Health News Source Type: news
NHS drive to save £150million for cheaper 'biosimilars' may have left THOUSANDS in agony
Amanda Wayne (pictured), 34, a design studio manager from Enfield, was swapped from Humira to Amgevita for her Crohn's disease in February 2019. (Source: the Mail online | Health)
Source: the Mail online | Health - October 29, 2022 Category: Consumer Health News Source Type: news
Upadacitinib Maintenance Triples Clinical Remissions in Crohn's Disease
(MedPage Today) -- Depending on the dose, maintenance upadacitinib (Rinvoq) either doubled or tripled clinical remissions at 1 year in patients with moderately to severely active Crohn's disease, the phase III U-ENDURE trial showed.
In an intention... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 27, 2022 Category: Gastroenterology Source Type: news
Risk for All-Cause Mortality No Higher With Inflammatory Bowel Disease
MONDAY, Oct. 24, 2022 -- The risk for cardiovascular diseases and infections may be higher in some subgroups of Crohn disease (CD) patients, according to a study published online Oct. 14 in the Journal of Crohn ' s and Colitis.
Benoit Follin-Arbelet,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 24, 2022 Category: Pharmaceuticals Source Type: news
New TREMFYA ® (guselkumab) Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2b QUASAR Induction Study 1 in adults with moderately to severely active ulcerative colitis (UC) with inadequate responses to previous treatments. The data presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting show an overall clinical response rate of approximately 80 percent in patients who were randomized to TREMFYA® (guselkumab).Clinical responsea at weeks 12 or 24 of the study was ultimately achieved by 80.2 percent of patients who w...
Source: Johnson and Johnson - October 24, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Crohn's Disease: What Is Remission?
Crohn's disease remission is more than just a lack of symptoms. Find out what's considered remission for Crohn's disease. (Source: WebMD Health)
Source: WebMD Health - October 21, 2022 Category: Consumer Health News Source Type: news
Experts Answer Your Questions About Crohn's Disease
So you've been diagnosed with Crohn's disease. You have some questions. We have some experts with some answers. (Source: WebMD Health)
Source: WebMD Health - October 21, 2022 Category: Consumer Health News Source Type: news
